Vermillion this week announced that its stockholders have voted to approve the reappointment of Gail Page, John Hamilton, and William Wallen as directors of the company.
Page, Vermillion's CEO, joined the company in January 2004 and has been a director since 2005. Hamilton has been on the company's board since April 2008. Prior to that he was vice president and chief financial officer of Depomed. Wallen was appointed to the board in February, before which he was a member of the company's scientific advisory board. Previously he was senior vice president and chief scientific officer at Idexx Laboratories.
Martin Madaus has joined the board of directors for array maker Quanterix.
Madaus recently was president, CEO, and chairman for Millipore, and before that he was president and CEO at Roche Diagnostics and vice president of business development for Roche Molecular Diagnostics. He currently is a director of the Massachusetts High Technology Council.